Atlas Trials

Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)

Clinical trial NCT01391182 · COMPLETED

Trial details

NCT number
NCT01391182
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Degenerative Joint DiseaseOsteoarthritis
Start date
2011-07-01
Primary completion
2015-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.